G Medical Innovations (GMVD) Stock Price, News & Analysis

Company Overview

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.16 to $0.38
• 52-Week Range: N/A
• Volume: 2.86 million shs
• Average Volume: 1.13 million shs
• Market Capitalization: $355 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GMVD Stock Analysis - Frequently Asked Questions

When did G Medical Innovations' stock split?

Shares of G Medical Innovations reverse split on the morning of Saturday, November 19th 2022. The 1-35 reverse split was announced on Saturday, November 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Saturday, November 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did G Medical Innovations IPO?

G Medical Innovations (GMVD) raised $8 million in an initial public offering (IPO) on Friday, June 25th 2021. The company issued 3,000,000 shares at a price of $5.00-$0.00 per share.

What other stocks do shareholders of G Medical Innovations own?

Based on aggregate information from My MarketBeat watchlists, some other companies that G Medical Innovations investors own include HubSpot (HUBS), Tesla (TSLA), Pfizer (PFE), Diamondback Energy (FANG), ForgeRock (FORG) and Netflix (NFLX).

Company Calendar

• Today: 6/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: N/A
• Current Symbol: NASDAQ:GMVD
• CIK: 1760764
• Web: gmedinnovations.com
• Phone: 972-8958-4777
• Fax: N/A
• Employees: 84
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.22
• Quick Ratio: 0.19

Sales & Book Value

• Annual Sales: $4.42 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($3.21) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,964,000
• Free Float: 1,235,000
• Market Cap: $355 thousand
• Optionable: Not Optionable
• Beta: N/A